Omega-3-acid ethyl esters and Pulmonary oedema aggravated - a phase IV clinical study of FDA data

Summary:

Pulmonary oedema aggravated is reported only by a few people who take Omega-3-Acid Ethyl Esters.

The phase IV clinical study analyzes which people take Omega-3-acid ethyl esters and have Pulmonary oedema aggravated. It is created by eHealthMe based on reports of 1,268 people who have side effects while taking Omega-3-acid ethyl esters from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

1,268 people reported to have side effects when taking Omega-3-acid ethyl esters.
Among them, 4 people (0.32%) have Pulmonary oedema aggravated.


What is Omega-3-acid ethyl esters?

Omega-3-acid ethyl esters has active ingredients of omega-3-acid ethyl esters. eHealthMe is studying from 1,332 Omega-3-acid ethyl esters users for its effectiveness, alternative drugs and more.

What is Pulmonary oedema aggravated?

Pulmonary oedema aggravated (aggravated fluid accumulation in the lungs) is found to be associated with 691 drugs and 361 conditions by eHealthMe.

Number of Omega-3-acid ethyl esters and Pulmonary oedema aggravated reports submitted per year:

Could Omega-3-acid ethyl esters cause Pulmonary oedema aggravated?

Time on Omega-3-acid ethyl esters when people have Pulmonary oedema aggravated *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Pulmonary oedema aggravated when taking Omega-3-acid ethyl esters *:

  • female: 25 %
  • male: 75 %

Age of people who have Pulmonary oedema aggravated when taking Omega-3-acid ethyl esters *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Omega-3-acid ethyl esters *:

  1. Plavix: 2 people, 50.00%
  2. Novolog: 1 person, 25.00%
  3. Metformin: 1 person, 25.00%
  4. Magnesium: 1 person, 25.00%
  5. Inspra: 1 person, 25.00%
  6. Enbrel: 1 person, 25.00%
  7. Crestor: 1 person, 25.00%
  8. Cordarone: 1 person, 25.00%

Common side effects people have besides Pulmonary oedema aggravated *:

  1. Traumatic Lung Injury: 1 person, 25.00%
  2. Sinusitis (inflammation of sinus): 1 person, 25.00%
  3. Septic Shock (shock due to blood infection): 1 person, 25.00%
  4. Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 25.00%
  5. Breathing Difficulty: 1 person, 25.00%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 25.00%
  7. Arrhythmias (irregular heartbeat): 1 person, 25.00%
  8. Acute Respiratory Failure: 1 person, 25.00%
  9. Acute Myocardial Infarction (acute heart attack): 1 person, 25.00%

Common conditions people have *:

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Omega-3-acid ethyl esters and have Pulmonary oedema aggravated?

Check whether Pulmonary oedema aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Omega-3-acid ethyl esters:

Pulmonary oedema aggravated treatments and more:

COVID vaccines that are related to Pulmonary oedema aggravated:

How severe was Pulmonary oedema aggravated and when was it recovered:

Expand to all the drugs that have ingredients of omega-3-acid ethyl esters:

Common drugs associated with Pulmonary oedema aggravated:

All the drugs that are associated with Pulmonary oedema aggravated:

Common conditions associated with Pulmonary oedema aggravated:

All the conditions that are associated with Pulmonary oedema aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on omega-3-acid ethyl esters (the active ingredients of Omega-3-acid ethyl esters) and Omega-3-acid ethyl esters (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: